Edition:
United Kingdom

Cellectar Biosciences Inc (CLRB.OQ)

CLRB.OQ on NASDAQ Stock Exchange Capital Market

2.18USD
21 Aug 2019
Change (% chg)

-- (--)
Prev Close
$2.18
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
72,898
52-wk High
$4.25
52-wk Low
$1.22

About

Cellectar Biosciences, Inc., formerly Novelos Therapeutics, Inc., is a clinical stage biopharmaceutical company. The Company is engaged in developing phospholipid ether-drug conjugates (PDCs) for the treatment and diagnostic imaging of cancer. Its research and development program is based on its PDC cancer targeting delivery... (more)

Overall

Beta: 1.16
Market Cap(Mil.): $11.55
Shares Outstanding(Mil.): 5.40
Dividend: --
Yield (%): --

Financials

  CLRB.OQ Industry Sector
P/E (TTM): -- 29.73 33.85
EPS (TTM): -4.83 -- --
ROI: -150.37 13.04 12.69
ROE: -210.13 14.12 17.13
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates